123 related articles for article (PubMed ID: 31393570)
1. Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study.
Nordenström A; Svensson J; Lajic S; Frisén L; Nordenskjöld A; Norrby C; Almqvist C; Falhammar H
J Clin Endocrinol Metab; 2019 Dec; 104(12):6148-6154. PubMed ID: 31393570
[TBL] [Abstract][Full Text] [Related]
2. Are carriers of CYP21A2 mutations less vulnerable to psychological stress? A population-based national cohort study.
Nordenström A; Butwicka A; Lindén Hirschberg A; Almqvist C; Nordenskjöld A; Falhammar H; Frisén L
Clin Endocrinol (Oxf); 2017 Mar; 86(3):317-324. PubMed ID: 27654981
[TBL] [Abstract][Full Text] [Related]
3. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
[TBL] [Abstract][Full Text] [Related]
4. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Frisén L; Norrby C; Hirschberg AL; Almqvist C; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2715-21. PubMed ID: 25279502
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
6. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study.
Engberg H; Butwicka A; Nordenström A; Hirschberg AL; Falhammar H; Lichtenstein P; Nordenskjöld A; Frisén L; Landén M
Psychoneuroendocrinology; 2015 Oct; 60():195-205. PubMed ID: 26184920
[TBL] [Abstract][Full Text] [Related]
7. Differences in hormonal levels between heterozygous
Silva RS; Carvalho B; Pedro J; Castro-Correia C; Carvalho D; Carvalho F; Fontoura M
Arch Endocrinol Metab; 2022 Apr; 66(2):168-175. PubMed ID: 35289513
[TBL] [Abstract][Full Text] [Related]
8. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden.
Strandqvist A; Falhammar H; Lichtenstein P; Hirschberg AL; Wedell A; Norrby C; Nordenskjöld A; Frisén L; Nordenström A
J Clin Endocrinol Metab; 2014 Apr; 99(4):1425-32. PubMed ID: 24476073
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
10. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.
Gidlöf S; Falhammar H; Thilén A; von Döbeln U; Ritzén M; Wedell A; Nordenström A
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):35-42. PubMed ID: 24622265
[TBL] [Abstract][Full Text] [Related]
11. Genetic defects in the cyp21a2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia.
Neocleous V; Shammas C; Phedonos AP; Karaoli E; Kyriakou A; Toumba M; Phylactou LA; Skordis N
Georgian Med News; 2012 Sep; (210):40-7. PubMed ID: 23045419
[TBL] [Abstract][Full Text] [Related]
12. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
[TBL] [Abstract][Full Text] [Related]
13. Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Butwicka A; Landén M; Lichtenstein P; Nordenskjöld A; Nordenström A; Frisén L
J Clin Endocrinol Metab; 2014 Mar; 99(3):E554-60. PubMed ID: 24302749
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.
Bidet M; Bellanné-Chantelot C; Galand-Portier MB; Tardy V; Billaud L; Laborde K; Coussieu C; Morel Y; Vaury C; Golmard JL; Claustre A; Mornet E; Chakhtoura Z; Mowszowicz I; Bachelot A; Touraine P; Kuttenn F
J Clin Endocrinol Metab; 2009 May; 94(5):1570-8. PubMed ID: 19208730
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
[TBL] [Abstract][Full Text] [Related]
16. Phenotype heterogeneity of congenital adrenal hyperplasia due to genetic mosaicism and concomitant nephrogenic diabetes insipidus in a sibling.
Kor Y; Zou M; Al-Rijjal RA; Monies D; Meyer BF; Shi Y
BMC Med Genet; 2018 Jul; 19(1):115. PubMed ID: 29996815
[TBL] [Abstract][Full Text] [Related]
17. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia.
Wang W; Han R; Yang Z; Zheng S; Li H; Wan Z; Qi Y; Sun S; Ye L; Ning G
J Steroid Biochem Mol Biol; 2021 Jul; 211():105899. PubMed ID: 33864926
[TBL] [Abstract][Full Text] [Related]
18. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
[TBL] [Abstract][Full Text] [Related]
20. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.
Falhammar H; Frisén L; Hirschberg AL; Norrby C; Almqvist C; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2015 Sep; 100(9):3520-8. PubMed ID: 26126207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
